Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma

National Cheng Kung University Hospital, Tainan City

UCL Cliniques universitaires Saint-Luc, Woluwe-Saint-Lambert

Hospital Universitario Vall d'Hebron, Barcelona

Universitair Ziekenhuis Gent, Ghent

University of Pennsylsvania - Perelman Cancer Center for Advanced Medicine, Philadelphia

Georgetown Unversity Lombardi Comprehensive Cancer Center, Washington D.C.

IRCCS Ospedale San Raffaele S.r.l. - PPDS, Milan

McGuire VA Medical Center, Richmond

Duke University Cancer Center, Durham

General Universitario Gregorio Maranon, Madrid

START Madrid FJD, Hospital Universitario Fundacion Jimenez Diaz, Madrid

Hospital Universitario HM Sanchinarro, Madrid

Clínica Universidad de Navarra, Pamplona

Institut Bergonié, Bordeaux

Hôpital Haut-Lévêque - CHU de Bordeaux, Pessac

Centre Eugène Marquis, Rennes

Hospital Universitario Marques de Valdecilla, Santander

Taichung Veterans General Hospital, Taichung

Hospital Universitario Virgen del Rocio, Seville

Azienda Ospedaliero Universitaria - Policlinico di Modena, Modena

University of Cincinnati Cancer Institute, Cincinnati

IRCCS Istituto Scientifico Romagnolo per lo studio e la cura dei tumori - U.O. di Oncologia Medica, Meldola

Barbara Ann Karmanos Cancer Institute, Detroit

Centre Oscar Lambret, Lille

Northwestern Unversity, Chicago

Simmons Comprehensive Cancer Center, Dallas

University of Texas Southwestern Medical Center, Dallas

USC/Norris Comprehensive Cancer Center, Los Angeles

UCLA Medical Center, Santa Monica

Hoag Memorial Hospital Presbyterian, Newport Beach

Russian Oncology Research Center n a N N Blokhin, Moscow

National University Cancer Insitute, Singapore

Railway Clinical Hospital JSC RZhD, Saint Petersburg

City Clinical Oncology Dispensary, Saint Petersburg

Omsk Regional Oncology Center, Omsk

Altay Regional Oncology Center, Barnaul

UC Irvine Medical Center, Orange

Massachusetts General Hospital, Boston

John theurer Cancer Center at Hackensack University Medical Center, Hackensack

Cross Cancer Institute, Edmonton

Jurvanski Cancer Center, Hamilton

Asan Medical Center, Seoul

Hospital Universitario de Badajoz, Badajoz

Sarah Cannon Research Institute UK - SCRI - PPDS, London